Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Alembic Global Downgrades Albany Intl to Neutral

Alembic Global analyst Peter Skibitski downgrades Albany Intl (NYSE:AIN) from Overweight to Neutral.

byBenzinga Newsdesk

August 16, 2022

1 minute read

Alembic Global analyst Peter Skibitski downgrades Albany Intl (NYSE:AIN) from Overweight to Neutral.

News

Vivos Therapeutics Announces Exclusive Distribution Agreement With GM Instruments, Ltd. In US And Canada For GM Instruments’ NR6 Rhinomanometer

By Bill Haddad

Today, 9:25 AM

Vivos Therapeutics, Inc. (NASDAQ:VVOS) ("Vivos" or "the Company"), a revenue-stage medical technology company focused on developing innovative treatments for patients suffering from

VVOS

Allakos Q2 EPS $(1.07) Down From $(0.80) YoY

By Benzinga Newsdesk

Today, 9:25 AM

Allakos (NASDAQ:ALLK) reported quarterly losses of $(1.07) per share. This is a 33.75 percent decrease over losses of $(0.80) per share from the same period last year.

ALLK

Ukraine’s Zelensky Tells G7 Now Is Not the Time for Negotiations With Russia

By Charles Gross

Today, 9:25 AM

-AFP Citing French Presidency https://twitter.com/AFP/status/1541382794466803714

RSX

News

Why Creatd Stock Is Trading Higher Today

By Tyree Gorges

Today, 9:25 AM

Creatd (NASDAQ: CRTD) shares are trading higher after the company announced a second NFT drop, which is a series of three photographs of former President Donald Trump.

CRTD

Alembic Global Downgrades Albany Intl to Neutral

Related Posts

Vivos Therapeutics Announces Exclusive Distribution Agreement With GM Instruments, Ltd. In US And Canada For GM Instruments’ NR6 Rhinomanometer

Allakos Q2 EPS $(1.07) Down From $(0.80) YoY

Ukraine’s Zelensky Tells G7 Now Is Not the Time for Negotiations With Russia

Why Creatd Stock Is Trading Higher Today